Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells $13,086.89 in Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Emma S. Battle sold 1,693 shares of the business’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $7.73, for a total value of $13,086.89. Following the sale, the director now owns 17,530 shares of the company’s stock, valued at $135,506.90. The trade was a 8.81 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Nu Skin Enterprises Price Performance

NUS stock opened at $8.11 on Wednesday. The firm has a market cap of $402.98 million, a P/E ratio of -2.75 and a beta of 1.17. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $14.04. The stock has a 50-day simple moving average of $6.89 and a 200-day simple moving average of $7.29.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. The firm had revenue of $445.55 million during the quarter, compared to analysts’ expectations of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, equities analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 5th. Investors of record on Monday, February 24th will be paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 2.96%. The ex-dividend date is Monday, February 24th. Nu Skin Enterprises’s dividend payout ratio (DPR) is -8.14%.

Hedge Funds Weigh In On Nu Skin Enterprises

Institutional investors have recently added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at about $25,000. US Bancorp DE lifted its stake in shares of Nu Skin Enterprises by 424.2% in the fourth quarter. US Bancorp DE now owns 7,460 shares of the company’s stock worth $51,000 after acquiring an additional 6,037 shares in the last quarter. Public Employees Retirement System of Ohio boosted its holdings in Nu Skin Enterprises by 28.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company’s stock valued at $55,000 after purchasing an additional 1,768 shares during the last quarter. Signaturefd LLC grew its stake in Nu Skin Enterprises by 536.8% during the 4th quarter. Signaturefd LLC now owns 8,087 shares of the company’s stock valued at $56,000 after purchasing an additional 6,817 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in Nu Skin Enterprises by 2,412.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company’s stock worth $57,000 after purchasing an additional 7,888 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Wall Street Analysts Forecast Growth

NUS has been the subject of several research reports. DA Davidson decreased their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.